About Guangzhou Zhiyi Pharmaceutics
Guangzhou Zhiyi Pharmaceutics is a company based in Guangzhou (China) founded in 2013.. Guangzhou Zhiyi Pharmaceutics has raised $39.12 million across 5 funding rounds from investors including Guangdong Investment, SDIC Venture Capital and Guangzhou Development Zone. Guangzhou Zhiyi Pharmaceutics operates in a competitive market with competitors including Novozymes, Phathom Pharmaceuticals, Seed, Seres Therapeutics and MaaT Pharma, among others.
- Headquarter Guangzhou, China
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$39.12 M (USD)
in 5 rounds
-
Latest Funding Round
-
Investors
Guangdong Investment
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Guangzhou Zhiyi Pharmaceutics
Guangzhou Zhiyi Pharmaceutics has successfully raised a total of $39.12M across 5 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 5
- Last Round Last Round
-
First Round
First Round
(01 Aug 2018)
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar, 2024 | Amount | Series C - Guangzhou Zhiyi Pharmaceutics | Valuation | Guangdong Investment |
|
| Jul, 2022 | Amount | Series B - Guangzhou Zhiyi Pharmaceutics | Valuation |
investors |
|
| Sep, 2021 | Amount | Series B - Guangzhou Zhiyi Pharmaceutics | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Guangzhou Zhiyi Pharmaceutics
Guangzhou Zhiyi Pharmaceutics has secured backing from 5 investors, including institutional and venture fund investors. Prominent investors backing the company include Guangdong Investment, SDIC Venture Capital and Guangzhou Development Zone. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are managed for innovative company growth.
|
Founded Year | Domain | Location | |
|
Venture capital, equity investment, and fund management services in China.
|
Founded Year | Domain | Location | |
|
Investment company
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Guangzhou Zhiyi Pharmaceutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Guangzhou Zhiyi Pharmaceutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Guangzhou Zhiyi Pharmaceutics Comparisons
Competitors of Guangzhou Zhiyi Pharmaceutics
Guangzhou Zhiyi Pharmaceutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Novozymes, Phathom Pharmaceuticals, Seed, Seres Therapeutics and MaaT Pharma, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Biosolutions and enzymes are developed for biotechnology applications across industries.
|
|
| domain | founded_year | HQ Location |
Therapies for gastrointestinal diseases are developed by Phathom Pharmaceuticals.
|
|
| domain | founded_year | HQ Location |
Synbiotics are developed for simulating the gut microbiome.
|
|
| domain | founded_year | HQ Location |
Microbiome therapeutics are developed to address diverse diseases.
|
|
| domain | founded_year | HQ Location |
Microbiome therapies are developed for treating intestinal dysbiosis diseases.
|
|
| domain | founded_year | HQ Location |
Microbiome-based immuno-oncology drugs are developed using proprietary technology.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Guangzhou Zhiyi Pharmaceutics
Frequently Asked Questions about Guangzhou Zhiyi Pharmaceutics
When was Guangzhou Zhiyi Pharmaceutics founded?
Guangzhou Zhiyi Pharmaceutics was founded in 2013 and raised its 1st funding round 5 years after it was founded.
Where is Guangzhou Zhiyi Pharmaceutics located?
Guangzhou Zhiyi Pharmaceutics is headquartered in Guangzhou, China. It is registered at Guangzhou, Guangdong, China.
Who is the current CEO of Guangzhou Zhiyi Pharmaceutics?
Ye Wang is the current CEO of Guangzhou Zhiyi Pharmaceutics.
Is Guangzhou Zhiyi Pharmaceutics a funded company?
Guangzhou Zhiyi Pharmaceutics is a funded company, having raised a total of $39.12M across 5 funding rounds to date.
What does Guangzhou Zhiyi Pharmaceutics do?
Guangzhou Zhiyi Pharmaceutics was founded in 2013 in Guangzhou, China, as a biotechnology firm. Second-generation probiotics are developed by the company to address antibiotic-associated diarrhea and Clostridium difficile-associated diarrhea, with the lead candidate in the preclinical stage. Additional candidates target ulcerative colitis. Fermentation and separation of active products are offered as services within the gastrointestinal therapeutics sector.
Who are the top competitors of Guangzhou Zhiyi Pharmaceutics?
Guangzhou Zhiyi Pharmaceutics's top competitors include Phathom Pharmaceuticals, Novozymes and Seres Therapeutics.
Who are Guangzhou Zhiyi Pharmaceutics's investors?
Guangzhou Zhiyi Pharmaceutics has 5 investors. Key investors include Guangdong Investment, SDIC Venture Capital, Guangzhou Development Zone, SinoKing Capital, and Shenzhen Capital Group.